Laparascopic cholecystectomy. ?????? ??? ???? ?????????? ?????? ? ???????
Conditions
Interventions
Intervention 1: Intervention group: Honey syrup will be produced by NIAK Pharmaceutical Company with the license of the Food and Drug Administration of the Ministry of Health and Medical Education wit
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Laparoscopic gallbladder surgery,,, age between 18 and 65 years , NPO BMI between 18 and 30, PS patients one and two (either have no underlying disease or have controlled underlying disease) tend to Participate in the study and give informed consent
Exclusion criteria
Exclusion criteria: Having vestibular symptoms (nausea caused by ear diseases) Known gastrointestinal diseases (such as colitis, gastritis, etc.) Drug and benzodiazepine addiction Having nausea Unawareness and having psychotic symptoms Have a history of allergies to honey compounds (especially cinnamon or other plants with similar families) Being pregnant while studying Consumption of antiemetics and vomiting other than the treatment protocol The patient's inability to continue cooperating for any reason, such as loss of consciousness, death of the patient Inability of the patient to determine the severity of nausea and bloating despite the instructions Complete lack of access to the patient Changes in surgical procedures and intraoperative anesthesia for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea score based on visual analog scale. Timepoint: Upon entering the operating room, during recovery, 2 and 24 hours after surgery. Method of measurement: Visual analog scale.;Number of vomiting times based on patient observation. Timepoint: Upon entering the operating room, during recovery, 2 and 24 hours after surgery. Method of measurement: Patient observation.;Variable bloating score based on visual analog scale. Timepoint: Upon entering the operating room, during recovery, 2 and 24 hours after surgery. Method of measurement: visual analog scale.;Pain variable score based on visual analog scale. Timepoint: Upon entering the operating room, during recovery, 2 and 24 hours after surgery. Method of measurement: visual analog scale.;Recovery quality score based on QOR-40 questionnaire (40-200). Timepoint: 2, 12 and 24 hours after surgery. Method of measurement: Recovery Quality Questionnaire (QOR-40). | — |
Secondary
| Measure | Time frame |
|---|---|
| Intensity of the feeling of hunger. Timepoint: Upon entering the operating room. Method of measurement: Question from the patient.;Intense feeling of thirst. Timepoint: Upon entering the operating room. Method of measurement: Question from the patient.;Blood pressure level. Timepoint: Upon entering the operating room before induction of anesthesia, after co2 gas injection, in the recovery section, at the time of discharge from recovery and 2 hours after surgery. Method of measurement: Blood pressure manometer and vital signs monitor.;Heart rate. Timepoint: Upon entering the operating room before induction of anesthesia, after co2 gas injection, in the recovery section, at the time of discharge from recovery and 2 hours after surgery. Method of measurement: Vital Signal Monitor and Pulse Oximeter.;Shivering score based on Crossley criteria. Timepoint: In the recovery section and 2 hours after the operation. Method of measurement: Crossley criteria.;Intensity of shoulder pain. Timepoint: When discharge from recovery, 2 and 24 hours after surgery. Method of measurement: Observe and ask the patient.;Intensity of Headache, dry mouth, feeling cold, feeling weak, feeling tired before the operation. Timepoint: Upon entering the operating room. Method of measurement: Observe and ask the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSahar Ghorban Shamsi
Mazandaran University of Medical Sciences
Outcome results
None listed